![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DM Chuang, XM Gao and SM Paul
Section on Molecular Neurobiology, National Institute of Mental Health, Bethesda, Maryland 20892.
Exposure of cultured cerebellar granule cells to glutamate results in a concentration-dependent (EC50 = 22.7 +/- 0.4 microM) and delayed (24-72 hr) neurotoxicity, which is blocked by the specific N-methyl-D- aspartate (NMDA) receptor antagonists 2-amino-5-phosphovalerate and MK- 801 but is unaffected by the non-NMDA receptor antagonists 6-cyano-7- nitroquinoxaline-2,3-dione and 6,7-dinitroquinoxaline-2,3-dione. Although glutamate toxicity in these cells is mediated by the NMDA subtype of glutamate receptor, pretreatment of cerebellar granule cells with subtoxic concentrations of NMDA markedly antagonizes the neurotoxic actions of glutamate, with an IC50 of 55 +/- 4 microM. The neuroprotective effect of NMDA requires a preincubation time of approximately 120 min to be fully manifested and does not require the presence of NMDA during glutamate exposure. These data demonstrate that NMDA receptors mediate both neurotoxicity and neuroprotection in cerebellar granule cells. Among four glutamate receptor agonists tested (NMDA, quisqualate, ibotenate, and kainate), only NMDA was able to provide a robust neuroprotection against glutamate toxicity. Quisqualate was neither neurotoxic nor neuroprotective, whereas ibotenate, which was nontoxic by itself, induced a small degree of neuroprotection. In contrast, kainate, which was neurotoxic to cerebellar granule cells, also provided considerable neuroprotection against glutamate toxicity. Because preincubation of cerebellar granule cells with NMDA fails to alter NMDA receptor-mediated phosphoinositide hydrolysis or the specific binding of [3H]MK-801 to NMDA receptors, it appears that the neuroprotective effects of NMDA are not due to NMDA receptor desensitization.
This article has been cited by other articles:
|
|
 |
|
  F. X. Soriano, S. Papadia, F. Hofmann, N. R. Hardingham, H. Bading, and G. E. Hardingham Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J. Neurosci., April 26, 2006; 26(17): 4509 - 4518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Miao, X.-H. Yin, D.-S. Pei, Q.-G. Zhang, and G.-Y. Zhang Neuroprotective Effects of Preconditioning Ischemia on Ischemic Brain Injury through Down-regulating Activation of JNK1/2 via N-Methyl-D-aspartate Receptor-mediated Akt1 Activation J. Biol. Chem., June 10, 2005; 280(23): 21693 - 21699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Tang, X. Wang, X. Gong, M. Tong, D. Park, Z. Xia, and Z. Mao Cyclin-Dependent Kinase 5 Mediates Neurotoxin-Induced Degradation of the Transcription Factor Myocyte Enhancer Factor 2 J. Neurosci., May 11, 2005; 25(19): 4823 - 4834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lee, G. Q. Butcher, K. R. Hoyt, S. Impey, and K. Obrietan Activity-Dependent Neuroprotection and cAMP Response Element-Binding Protein (CREB): Kinase Coupling, Stimulus Intensity, and Temporal Regulation of CREB Phosphorylation at Serine 133 J. Neurosci., February 2, 2005; 25(5): 1137 - 1148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Wenninger, L. G. Pan, L. Klum, T. Leekley, J. Bastastic, M. R. Hodges, T. R. Feroah, S. Davis, and H. V. Forster Large lesions in the pre-Botzinger complex area eliminate eupneic respiratory rhythm in awake goats J Appl Physiol, November 1, 2004; 97(5): 1629 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Chalecka-Franaszek and D.-M. Chuang Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons PNAS, July 20, 1999; 96(15): 8745 - 8750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-W. Chen and D.-M. Chuang Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression. A PROMINENT ROLE IN NEUROPROTECTION AGAINST EXCITOTOXICITY J. Biol. Chem., March 5, 1999; 274(10): 6039 - 6042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nonaka, C. J. Hough, and D.-M. Chuang Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx PNAS, March 3, 1998; 95(5): 2642 - 2647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Du, K. R. Bales, R. C. Dodel, E. Hamilton-Byrd, J. W. Horn, D. L. Czilli, L. K. Simmons, B. Ni, and S. M. Paul Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons PNAS, October 14, 1997; 94(21): 11657 - 11662. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
